Prostaglandin E2 (Cervical Ripening / Induction of Labour)
Pregnancy: Indicated at term for induction — not for use in preterm labour induction (except specific indications)
Dinoprostone (Cervical Ripening / Induction of Labour)
Brand names: Prostin E2 (3 mg pessary), Propess (10 mg sustained-release pessary)
Adult dose
Dose: Prostin E2 3 mg pessary: insert vaginally; repeat after 6–8h if required (max 2 doses = 6 mg). Propess 10 mg sustained-release: insert vaginally; remove after 24h or at onset of active labour
Route: Vaginal pessary
Frequency: Prostin: up to 2 doses; Propess: single 24h insertion
Max: 6 mg total (Prostin); 10 mg (Propess single device)
Propess preferred in many units: slow-release over 24h, retrieval string allows removal if hyperstimulation occurs. Monitor CTG for 30 min after insertion. NICE NG207: IOL with dinoprostone or misoprostol as standard. ARM + oxytocin if Bishop score ≥6 after ripening.
Paediatric dose
Route: N/A
Frequency: N/A
Max: N/A
Not applicable in paediatric patients
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required
Clinical pearls
- Propess retrieval string: in hyperstimulation, removing the pessary rapidly reduces the prostaglandin dose — this is a key safety advantage over Prostin
- Do NOT use dinoprostone in women with previous CS without full counselling and consultant review — risk of uterine rupture
- CTG monitoring: continuous for 30 min after insertion; intermittent monitoring thereafter per local protocol
- Oxytocin timing: wait minimum 30 min after Propess removal (or 6h after Prostin) before commencing oxytocin
- NICE NG207 (2021 IOL guidelines): dinoprostone and misoprostol both acceptable; choice per local protocol
Contraindications
- Previous uterine scar (CS or myomectomy) — relative contraindication (higher rupture risk); discuss risk
- Fetal distress (abnormal CTG)
- Active labour
- Unexplained antepartum haemorrhage
- Grand multiparity (≥5 previous births)
- Placenta praevia
Side effects
- Uterine hyperstimulation (most serious — remove Propess retrieval string immediately)
- Fetal distress (secondary to hyperstimulation)
- GI upset
- Fever
- Local vaginal discomfort
Interactions
- Oxytocin — do NOT commence within 6h of Prostin or after Propess removal (additive uterotonic risk)
- NSAIDs — may reduce prostaglandin efficacy
Monitoring
- CTG (continuous 30 min post-insertion; then per protocol)
- Uterine contraction frequency (hyperstimulation watch)
- Bishop score progression
- Fetal and maternal wellbeing
Reference: BNFc; NICE NG207 Inducing Labour (2021); RCOG IOL Guideline; BNF. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21